These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12515265)

  • 1. From the Centers for Disease Control and Prevention. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
    JAMA; 2003 Jan; 289(1):36-7. PubMed ID: 12515265
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(47):1065-7. PubMed ID: 12500906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.
    Teschke R; Genthner A; Wolff A
    J Ethnopharmacol; 2009 Jun; 123(3):378-84. PubMed ID: 19501269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another FDA warning: Kava supplements.
    Parkman CA
    Case Manager; 2002; 13(4):26-8. PubMed ID: 12131903
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of kava hepatotoxicity and the FDA consumer advisory.
    Teschke R; Schulze J
    JAMA; 2010 Nov; 304(19):2174-5. PubMed ID: 21081732
    [No Abstract]   [Full Text] [Related]  

  • 6. Kava hepatotoxicity--a clinical review.
    Teschke R
    Ann Hepatol; 2010; 9(3):251-65. PubMed ID: 20720265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation and the use of KAVA: Case report.
    Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR
    Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava concerns. FDA, Botanical Council raises safety concerns.
    AWHONN Lifelines; 2002; 6(1):13-5. PubMed ID: 11971236
    [No Abstract]   [Full Text] [Related]  

  • 9. Are dietary supplements safe?
    Kam RY
    HDA Now; 2013; ():18-9. PubMed ID: 24427969
    [No Abstract]   [Full Text] [Related]  

  • 10. Kava-induced fulminant hepatic failure.
    Campo JV; McNabb J; Perel JM; Mazariegos GV; Hasegawa SL; Reyes J
    J Am Acad Child Adolesc Psychiatry; 2002 Jun; 41(6):631-2. PubMed ID: 12049436
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of ethanol in kava hepatotoxicity.
    Li XZ; Ramzan I
    Phytother Res; 2010 Apr; 24(4):475-80. PubMed ID: 19943335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal and Dietary Supplement-Induced Liver Injury.
    de Boer YS; Sherker AH
    Clin Liver Dis; 2017 Feb; 21(1):135-149. PubMed ID: 27842768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use?
    Currie BJ; Clough AR
    Med J Aust; 2003 May; 178(9):421-2. PubMed ID: 12720503
    [No Abstract]   [Full Text] [Related]  

  • 14. Hazards of hindsight--monitoring the safety of nutritional supplements.
    Cohen PA
    N Engl J Med; 2014 Apr; 370(14):1277-80. PubMed ID: 24693886
    [No Abstract]   [Full Text] [Related]  

  • 15. Kava: a supplement to avoid.
    Consum Rep; 2003 Mar; 68(3):8. PubMed ID: 12599340
    [No Abstract]   [Full Text] [Related]  

  • 16. Kava hepatotoxicity: a European view.
    Teschke R; Schwarzenboeck A; Akinci A
    N Z Med J; 2008 Oct; 121(1283):90-8. PubMed ID: 18841189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis induced by Kava (Piper methysticum rhizoma).
    Stickel F; Baumüller HM; Seitz K; Vasilakis D; Seitz G; Seitz HK; Schuppan D
    J Hepatol; 2003 Jul; 39(1):62-7. PubMed ID: 12821045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbalife nutritional products and liver injury revisited.
    Ignarro L; Heber D; Henig YS; Bejar E
    J Hepatol; 2008 Aug; 49(2):291-3; author reply 293-4. PubMed ID: 18550201
    [No Abstract]   [Full Text] [Related]  

  • 19. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure.
    Estes JD; Stolpman D; Olyaei A; Corless CL; Ham JM; Schwartz JM; Orloff SL
    Arch Surg; 2003 Aug; 138(8):852-8. PubMed ID: 12912743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the Centers for Disease Control and Prevention. Severe isoniazid-associated hepatitis--New York, 1991-1993.
    JAMA; 1993 Aug; 270(7):809. PubMed ID: 8340970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.